Home
BlackThorn Therapeutics

BlackThorn Therapeutics Market Share Analysis for June 2026

Health > Biotechnology and Pharmaceuticals

Domainblackthornrx.com

Year Founded2013

Employees51 - 200

Annual Revenue$50M - $75M

BlackThorn Therapeutics

BlackThorn Therapeutics (including company regionals)

blackthornrx.com

See more website traffic and engagement information

BlackThorn Therapeutics Revenue up to June 2026 is 50M - 75M

revenue generated by BlackThorn Therapeutics top domains

BlackThorn Therapeutics top domains revenue over 3 years

Revenue for BlackThorn Therapeutics top domains

blackthornrx.com50M - 75M

See more with Sales Intelligence

Total visits to BlackThorn Therapeutics's top domains

Understand BlackThorn Therapeutics market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in BlackThorn Therapeutics's top domains

Analyze BlackThorn Therapeutics engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on BlackThorn Therapeutics's top domains

See how BlackThorn Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

BlackThorn Therapeutics top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by BlackThorn Therapeutics

These are the website technologies, by industry, used by BlackThorn Therapeutics top domains

Widget (4)

Twemoji

Content Management System (3)

WordPress

Email Services (2)

G Suite

Mobile (2)

Meta Viewport

More Technologies

6

See all

News & Signals from BlackThorn Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsNeumoratx acquired Blackthornrx on Jan 1st '21.Neumora acquired BlackThorn when it was launched in 2021 and later added patients with moderate-to-severe MDD to the trial plan.

NewsBlackthornrx hired William J. Martin as Board of Directors on Oct 21st '19.BlackThorn Therapeutics Appoints William J. Martin, Ph.D., as Chief Executive Officer to Lead Next Stage of Growth SAN FRANCISCO, October 21, 2019 – BlackThorn Therapeutics, Inc., today announced the promotion of company co-founder and seasoned CNS drug discovery and development expert, William J. Martin, Ph.D., to chief executive officer and his appointment to the Board of Directors.

NewsBlackthornrx hired Monique Levy as chief strategy officer on Sep 9th '19.BlackThorn Therapeutics, Inc., a clinical-stage, neurobehavioral health company pioneering next-generation artificial intelligence (AI) technologies to advance targeted therapeutics, today announced the appointment of Monique Levy as chief strategy officer.